01513 LIVZON PHARMA
Closed Add to Porfolio| Key Financial Ratio (Fiscal Year: 12/2025) | |||
| Current | 2.23X | Oper Margin | 24.0% |
|---|---|---|---|
| LT Debt/Equity | 5.5% | Net Margin | 16.8% |
| Total Debt/Equity | 20.8% | Return on Equity | 14.6% |
| Price/Book | 1.71X | Return on Assets | 8.4% |
| (HKD 29.200) | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
| Net Profit (MHKD) | 2,252.08 | 2,191.98 | 2,153.31 | 2,140.83 | 2,171.84 |
|---|---|---|---|---|---|
| Net Profit Growth (%) | +2.7 | +1.8 | +0.6 | -1.4 | +6.7 |
| Earnings Per Share (HKD) | 2.522 | 2.382 | 2.318 | 2.29 | 2.322 |
| Earnings Per Share Growth (%) | +5.9 | +2.8 | +1.2 | -1.4 | +6.8 |
| Dividend Per Share (HKD) | 1.592 | 1.199 | 1.482 | 1.744 | 1.512 |
| P/E* (X) | 11.58 | 12.26 | 12.60 | 12.75 | 12.58 |
| Yield (%) | 5.45 | 4.11 | 5.08 | 5.97 | 5.18 |
| Dividend Share (%) | 63.12 | 50.33 | 63.95 | 76.16 | 65.10 |
| Book NAV (HKD) | 17.099 | 16.177 | 16.752 | 16.630 | 16.959 |
| Auditors' Opinion | Unqualified | Unqualified | Unqualified | Unqualified | Unqualified |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2026-04-02 21:40:20
Latest Result
| (RMBMn) | 2025-12 | 2024-12 | Chg* (%) | 2023-12 |
| Cover Period (mths) | 12 | 12 | NA | 12 |
|---|---|---|---|---|
| Turnover | 12,020 | 11,812 | +1.8 | 12,430 |
| Operating Result | 2,903 | 2,789 | +4.1 | 2,357 |
| Associates | 44.017 | 9.87 | +346.0 | 58.461 |
| Profit Before Taxation | 2,862 | 2,806 | +2.0 | 2,383 |
| Taxation | 451.011 | 501.661 | -10.1 | 485.066 |
| Profit /( Loss) After Taxation | 2,411 | 2,304 | +4.6 | 1,898 |
| Minority Interests | 387.79 | 243.389 | +59.3 | -56.05 |
| Net Profit | 2,023 | 2,061 | -1.8 | 1,954 |
| Earnings Per Share () | 2.5216 | 2.3817 | +5.9 | 2.3176 |
| Dividend Per Share () | 1.5917 | 1.1988 | +32.8 | 1.4820 |
| Announcement Date | 2026-03-24 | 2025-03-26 | NA | 2024-03-28 |
* Annualised
Last Update Time: 2026-04-02 21:40:25
